newsfilter
← Latest News
PR Newswire·

Tryp Therapeutics to Participate in Healthcare Conferences in January 2022

SAN DIEGO, Jan. 5, 2022 /PRNewswire/ -- Tryp Therapeutics (CSE:TRYP) (OTCQB:TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, announced today that it